Trending FOX BUSINESS News: Novavax starts Phase 1 coronavirus vaccine trial after $388M from Bill Gates-backed group
Novavax starts Phase 1 coronavirus vaccine trial after $388M from Bill Gates-backed group
If Phase 1 is successful, Novavax will follow up with Phase 2 in multiple countries, including the U.S.
via FOX BUSINESS NEWS Markets
https://ift.tt/3gnTgsg
No comments